OneOncology Partner Practices Shine with 26 Abstracts at ASH Annual Meeting
Nashville, Tennessee - OneOncology, a pioneering platform led by physicians to enhance independent community oncology practices, is proud to announce that its partner practice investigators are set to present 26 oral and poster abstracts at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition. This significant event will take place from December 7 to 10, 2024, and marks an important milestone for the healthcare community, particularly in the field of hematology.
Partner practices contributing to these presentations include The Cancer and Hematology Centers from Michigan, New York Cancer and Blood Specialists, and Tennessee Oncology. These organizations are at the forefront of research in hematologic disorders, delivering vital insights that could improve patient outcomes significantly. Ian W. Flinn, MD, PhD, Chief Scientific Officer at OneOncology, stated, "Our practice partner investigator physicians are at the forefront of innovation in hematology. The breadth and depth of the research presented this year reflects our collective commitment to advancing scientific knowledge and improving outcomes for patients with hematologic disorders. We are excited to highlight these compelling studies at ASH 2024."
The array of research being shared spans various blood disorders and treatment innovations, showcasing the dedication of OneOncology to maintain excellence in the oncology field while promoting independent practices. This initiative aligns with OneOncology's overarching goal to provide patients with access to state-of-the-art therapies localized within their communities, thereby minimizing the need for hospital visits and supporting better healthcare management.
The abstracts stem from rigorous clinical trials and research initiatives designed to not only advance understanding within hematology but also to expand access to novel cancer treatments for patients. The conference allows for networking and knowledge-sharing among healthcare professionals, and the presentations from OneOncology’s partner practices will surely contribute significantly to the dialogue within the hematological community.
This opportunity illustrates OneOncology’s passion for empowering community oncologists and their practices, working tirelessly to help them navigate the complexities of clinical research and improve their patients' access to comprehensive care. With approximately 1,300 cancer care providers engaging with around 747,000 patients at more than 420 sites across the nation, the influence of OneOncology is expanding, promoting local oncology practices while enhancing their capacity to innovate.
As the ASH Annual Meeting approaches, anticipation builds around the invaluable research that will be presented. The OneOncology Research Network is ready to showcase the latest findings and advancements, underscoring their key role in the global fight against cancer. OneOncology stands firm in its mission to revolutionize cancer care, ensuring that community practices can thrive and that patients receive the best possible outcomes from their treatment regimens.
For further details about the oral and poster abstracts or to learn more about OneOncology and its commitment to community-based care, visit their official website or LinkedIn page. The ASH Meeting is poised to be a landmark event for sharing knowledge, collaboration, and driving forward the agenda for hematology research, and OneOncology is proud to be a part of this essential dialogue.
Partner practices contributing to these presentations include The Cancer and Hematology Centers from Michigan, New York Cancer and Blood Specialists, and Tennessee Oncology. These organizations are at the forefront of research in hematologic disorders, delivering vital insights that could improve patient outcomes significantly. Ian W. Flinn, MD, PhD, Chief Scientific Officer at OneOncology, stated, "Our practice partner investigator physicians are at the forefront of innovation in hematology. The breadth and depth of the research presented this year reflects our collective commitment to advancing scientific knowledge and improving outcomes for patients with hematologic disorders. We are excited to highlight these compelling studies at ASH 2024."
The array of research being shared spans various blood disorders and treatment innovations, showcasing the dedication of OneOncology to maintain excellence in the oncology field while promoting independent practices. This initiative aligns with OneOncology's overarching goal to provide patients with access to state-of-the-art therapies localized within their communities, thereby minimizing the need for hospital visits and supporting better healthcare management.
The abstracts stem from rigorous clinical trials and research initiatives designed to not only advance understanding within hematology but also to expand access to novel cancer treatments for patients. The conference allows for networking and knowledge-sharing among healthcare professionals, and the presentations from OneOncology’s partner practices will surely contribute significantly to the dialogue within the hematological community.
This opportunity illustrates OneOncology’s passion for empowering community oncologists and their practices, working tirelessly to help them navigate the complexities of clinical research and improve their patients' access to comprehensive care. With approximately 1,300 cancer care providers engaging with around 747,000 patients at more than 420 sites across the nation, the influence of OneOncology is expanding, promoting local oncology practices while enhancing their capacity to innovate.
As the ASH Annual Meeting approaches, anticipation builds around the invaluable research that will be presented. The OneOncology Research Network is ready to showcase the latest findings and advancements, underscoring their key role in the global fight against cancer. OneOncology stands firm in its mission to revolutionize cancer care, ensuring that community practices can thrive and that patients receive the best possible outcomes from their treatment regimens.
For further details about the oral and poster abstracts or to learn more about OneOncology and its commitment to community-based care, visit their official website or LinkedIn page. The ASH Meeting is poised to be a landmark event for sharing knowledge, collaboration, and driving forward the agenda for hematology research, and OneOncology is proud to be a part of this essential dialogue.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.